Doctors' perceptions of laboratory monitoring in office practice.

BACKGROUND Laboratory monitoring has been increasingly recognized as an important area for improving patient safety in ambulatory care. Little is known about doctors' attitudes towards laboratory monitoring and potential ways to improve it. METHODS Six focus groups and one individual interview with 20 primary care doctors and nine specialists from three Massachusetts communities. RESULTS Participants viewed laboratory monitoring as a critical, time-consuming task integral to their practice of medicine. Most believed they commit few laboratory monitoring errors and were surprised at the error rates reported in the literature. They listed various barriers to monitoring, including not knowing which doctor was responsible for ensuring the completion of laboratory monitoring, uncertainty regarding the necessity of monitoring, lack of alerts/reminders and patient non-adherence with recommended monitoring. The primary facilitator of monitoring was ordering laboratory tests while the patient is in the office. Primary care doctors felt more strongly than specialists that computerized alerts could improve laboratory monitoring. Participants wanted to individualize alerts for their practices and warned that alerts must not interrupt work flow or require too many clicks. CONCLUSIONS Doctors in community practice recognized the potential of computerized alerts to enhance their monitoring protocols for some medications. They viewed patient non-adherence as a barrier to optimal monitoring. Interventions to improve laboratory monitoring should address doctor workflow issues, in addition to patients' awareness of the importance of fulfilling recommended therapeutic monitoring to prevent adverse drug events.

[1]  M. Raebel,et al.  Evaluation of laboratory monitoring alerts within a computerized physician order entry system for medication orders. , 2006, The American journal of managed care.

[2]  R. Platt,et al.  Frequency of Serum Creatinine Monitoring During Allopurinol Therapy in Ambulatory Patients , 2006, The Annals of pharmacotherapy.

[3]  Robert L Davis,et al.  Baseline Laboratory Monitoring of Cardiovascular Medications in Elderly Health Maintenance Organization Enrollees , 2005, Journal of the American Geriatrics Society.

[4]  D J Graham,et al.  Liver enzyme monitoring in patients treated with troglitazone. , 2001, JAMA.

[5]  Joshua Borus,et al.  Adverse drug events in ambulatory care. , 2003, The New England journal of medicine.

[6]  Steven R. Simon,et al.  Laboratory monitoring of drugs at initiation of therapy in ambulatory care , 2005, Journal of General Internal Medicine.

[7]  Richard Platt,et al.  Laboratory monitoring of potassium and creatinine in ambulatory patients receiving angiotensin converting enzyme inhibitors and angiotensin receptor blockers , 2007, Pharmacoepidemiology and drug safety.

[8]  M. Kulldorff,et al.  Early detection of adverse drug events within population‐based health networks: application of sequential testing methods , 2007, Pharmacoepidemiology and drug safety.

[9]  Julia A. Kelleher,et al.  Randomized Trial to Improve Laboratory Safety Monitoring of Ongoing Drug Therapy in Ambulatory Patients , 2006, Pharmacotherapy.

[10]  Margaret J. Gunter,et al.  Brief report: Laboratory safety monitoring of chronic medications in ambulatory care settings , 2005, Journal of General Internal Medicine.

[11]  David W. Bates,et al.  Can surveillance systems identify and avert adverse drug events? A prospective evaluation of a commercial application. , 2008, Journal of the American Medical Informatics Association : JAMIA.

[12]  Steven R Simon,et al.  Improved therapeutic monitoring with several interventions: a randomized trial. , 2006, Archives of internal medicine.

[13]  Julie M. Fiskio,et al.  A randomized trial of electronic clinical reminders to improve medication laboratory monitoring. , 2008, Journal of the American Medical Informatics Association : JAMIA.

[14]  David W. Bates,et al.  Synthesis of Research Paper: Ten Commandments for Effective Clinical Decision Support: Making the Practice of Evidence-based Medicine a Reality , 2003, J. Am. Medical Informatics Assoc..

[15]  A. Melander,et al.  Systematic Review of the Incidence and Characteristics of Preventable Adverse Drug Events in Ambulatory Care , 2007, The Annals of pharmacotherapy.

[16]  Diane L. Seger,et al.  Research Paper: Impact of Non-interruptive Medication Laboratory Monitoring Alerts in Ambulatory Care , 2009, J. Am. Medical Informatics Assoc..

[17]  Julia A. Kelleher,et al.  Improving laboratory monitoring at initiation of drug therapy in ambulatory care: a randomized trial. , 2005, Archives of internal medicine.

[18]  Steven R. Simon,et al.  Case Report: Community-wide Implementation of Health Information Technology: The Massachusetts eHealth Collaborative Experience , 2009, J. Am. Medical Informatics Assoc..

[19]  D. Bates,et al.  Incidence and preventability of adverse drug events among older persons in the ambulatory setting. , 2003, JAMA.